Literature DB >> 12560273

Controlled trial of effect of documented cardiovascular risk scores on prescribing.

L M L Hall1, R T Jung, G P Leese.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12560273      PMCID: PMC140760          DOI: 10.1136/bmj.326.7383.251

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Updated New Zealand cardiovascular disease risk-benefit prediction guide.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

2.  Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

Authors:  J C LaRosa; J He; S Vupputuri
Journal:  JAMA       Date:  1999 Dec 22-29       Impact factor: 56.272

3.  Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.

Authors: 
Journal:  Lancet       Date:  2001-03-31       Impact factor: 79.321

4.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

5.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

  5 in total
  26 in total

1.  Cardiovascular risk scores and prescribing in diabetes. Using risk tables to assess cardiovascular risk in type 2 diabetes has drawbacks.

Authors:  Jamie Smith; Roger Corrall
Journal:  BMJ       Date:  2003-04-19

Review 2.  Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review.

Authors:  P Brindle; A Beswick; T Fahey; S Ebrahim
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

3.  Prognosis research and risk of bias.

Authors:  Gennaro D'Amico; Giuseppe Malizia; Mario D'Amico
Journal:  Intern Emerg Med       Date:  2016-02-24       Impact factor: 3.397

4.  A nonparametric updating method to correct clinical prediction model drift.

Authors:  Sharon E Davis; Robert A Greevy; Christopher Fonnesbeck; Thomas A Lasko; Colin G Walsh; Michael E Matheny
Journal:  J Am Med Inform Assoc       Date:  2019-12-01       Impact factor: 4.497

5.  A summary risk score for the prediction of Alzheimer disease in elderly persons.

Authors:  Christiane Reitz; Ming-Xin Tang; Nicole Schupf; Jennifer J Manly; Richard Mayeux; José A Luchsinger
Journal:  Arch Neurol       Date:  2010-07

6.  Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey.

Authors:  Stephen D Persell; Charles Zei; Kenzie A Cameron; Michael Zielinski; Donald M Lloyd-Jones
Journal:  Arch Intern Med       Date:  2010-03-08

Review 7.  Cardiovascular risk assessment and screening in diabetes.

Authors:  Yanglu Zhao
Journal:  Cardiovasc Endocrinol       Date:  2017-02-15

8.  The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus.

Authors:  A Dawson; A D Morris; A D Struthers
Journal:  Diabetologia       Date:  2005-08-11       Impact factor: 10.122

9.  Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial.

Authors:  Stephen D Persell; Donald M Lloyd-Jones; Elisha M Friesema; Andrew J Cooper; David W Baker
Journal:  J Gen Intern Med       Date:  2012-11-11       Impact factor: 5.128

Review 10.  Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians.

Authors:  Stacey Sheridan; Michael Pignone; Cynthia Mulrow
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.